| Name | Designation | Appointment Date | Status | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Chirag Girishbhai Patel
Appointed as Director since April 2005 |
Director | 01-Apr-2005 | Current | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Prakashkumar Shivramdas Patel
Appointed as Director since April 2010 |
Director | 01-Apr-2010 | Current | ||||||||||||||||||||||||||||
|
Vasantbhai Ambalal Raval
Appointed as Director since June 2014 |
Director | 16-Jun-2014 | Current | ||||||||||||||||||||||||||||
|
Pratik Girishbhai Patel
Appointed as Director since April 2005 |
Director | 01-Apr-2005 | Current | ||||||||||||||||||||||||||||
People Timeline
Explore the timeline of key personnel in Elikem Pharmaceuticals Private Limited's leadership journey.
Loading...
Contact Details
- Address Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1, At : Rakanpur, Tal : Ka, Lol,, Kalol Gujarat, 382721, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 382721
- Country India
- Website elikempharma.com
- Social Media
Frequently Asked Questions
How can I contact Elikem Pharmaceuticals Private Limited?
You can contact Elikem Pharmaceuticals Private Limited through their registered address at Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1, At : Rakanpur, Tal : Ka, Lol,, Kalol Gujarat, 382721, India, or via their website at elikempharma.com. Social media links are also provided where applicable.
Who are the current directors of Elikem Pharmaceuticals Private Limited?
The current directors of Elikem Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- PRAKASHKUMAR SHIVRAMDAS PATEL
- VASANTBHAI AMBALAL RAVAL
- CHIRAG GIRISHBHAI PATEL
- PRATIK GIRISHBHAI PATEL
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.